Previous close | 10,908.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 2,079,419 |
Market cap | 171.817B |
Beta (5Y monthly) | 0.17 |
PE ratio (TTM) | 33.31 |
EPS (TTM) | 3.27 |
Earnings date | 09 Nov 2023 |
Forward dividend & yield | 2.35 (2.15%) |
Ex-dividend date | 10 Aug 2023 |
1y target est | 130.11 |
Astrazeneca (AZN) concluded the recent trading session at $66.62, signifying a +0.54% move from its prior day's close.
Shares of Conduit Pharmaceuticals (NASDAQ: CDT) were up more than 17% on Wednesday as of 11:30 a.m., after jumping up as much as 81% in the first hour of trading, leading to a brief halt in trading. Conduit calls itself a "disease agnostic life science company." With no major news announced, Wednesday's brief meteoric rise was nearly as surprising as the big fall a day before.
AstraZeneca (AZN) agrees to pay $425 million to settle lawsuits related to heartburn drugs, Nexium and Prilosec.